日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PD-1 inhibitor treatment outcomes for cutaneous squamous cell carcinoma in patients over 85: a comparative analysis

PD-1抑制剂治疗85岁以上皮肤鳞状细胞癌患者的疗效:一项比较分析

Amir, Ido; Edri, Nofar; Averbuch, Itamar; Asher, Nethanel; Markel, Gal; Ritter, Amit; Yaniv, Dan; Zavdy, Ofir; Bachar, Gideon; Cooper, Lisa; Kurman, Noga; Yosefof, Eyal

A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases

比较肢体灌注/输注、免疫检查点抑制剂和病灶内治疗作为黑色素瘤转移患者一线治疗的疗效

DePalo, Danielle K; Dugan, Michelle M; Naqvi, Syeda Mahrukh Hussnain; Ollila, David W; Hieken, Tina J; Block, Matthew S; van Houdt, Winan J; Wouters, Michel W J M; Reijers, Sophie J M; Asher, Nethanel; Broman, Kristy K; Duncan, Zoey; Anderson, Matilda; Gyorki, David E; Snow, Hayden; Held, Jenny; Farma, Jeffrey M; Vetto, John T; Hui, Jane Y C; Kolbow, Madison; Saw, Robyn P M; Lo, Serigne N; Long, Georgina V; Thompson, John F; Kim, Youngchul; Karapetyan, Lilit; Ny, Lars; van Akkooi, Alexander C J; Olofsson Bagge, Roger; Zager, Jonathan S

Clinical outcomes following PD-1 inhibitor elective discontinuation in cutaneous squamous cell carcinoma: exploring treatment de-escalation

皮肤鳞状细胞癌患者选择性停用PD-1抑制剂后的临床结果:探索治疗降阶方案

Averbuch, Itamar; Edri, Nofar; Asher, Nethanel; Markel, Gal; Hendler, Daniel; Ditzian Kugler, Hadas; Yosefof, Eyal; Kurman, Noga

Treatment with programmed-death-1 inhibitors for non-melanoma skin cancer among immunocompromised patients with subgroup analysis of solid organ transplant patients

免疫功能低下患者非黑色素瘤皮肤癌患者接受程序性死亡受体1抑制剂治疗的疗效及实体器官移植患者亚组分析

Yosefof, Eyal; Edri, Nofar; Ben-Nachum, Idan; Yaniv, Dan; Mizrachi, Aviram; Asher, Nethanel; Ben-Dor, Naomi; Ben-Artzi, Avital; Averbuch, Itamar; Kurman, Noga

Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Melanoma

黑色素瘤患者使用免疫检查点抑制剂后发生神经系统免疫相关不良事件的发生率和预后

Pepys, Jack; Stoff, Ronen; Ramon-Gonen, Roni; Ben-Betzalel, Guy; Grynberg, Shirly; Frommer, Ronnie Shapira; Schachter, Jacob; Asher, Nethanel; Taliansky, Alisa; Nikitin, Vera; Dori, Amir; Shelly, Shahar

Better Late Than Never: The Impact of Steroidal Treatment on the Outcome of Melanoma Patients Treated with Immunotherapy

亡羊补牢,为时未晚:类固醇治疗对接受免疫疗法治疗的黑色素瘤患者预后的影响

Bar-Hai, Neta; Ben-Betzalel, Guy; Stoff, Ronen; Grynberg, Shirly; Schachter, Jacob; Shapira-Frommer, Ronnie; Asher, Nethanel

Real world evidence of Lenvatinib + anti PD-1 as an advanced line for metastatic melanoma

Lenvatinib联合抗PD-1疗法作为转移性黑色素瘤晚期治疗方案的真实世界证据

Stoff, Ronen; Asher, Nethanel; Laks, Shachar; Steinberg, Yael; Schachter, Jacob; Shapira-Frommer, Ronnie; Grynberg, Shirly; Ben-Betzalel, Guy

Avelumab for the treatment of locally advanced or metastatic Merkel cell carcinoma-A multicenter real-world experience in Israel

Avelumab治疗局部晚期或转移性默克尔细胞癌——以色列多中心真实世界经验

Averbuch, Itamar; Stoff, Ronen; Miodovnik, Mor; Fennig, Shlomit; Bar-Sela, Gil; Yakobson, Alexander; Daliot, Jonathan; Asher, Nethanel; Fenig, Eyal

Radiotherapy may augment response to immunotherapy in metastatic uveal melanoma patients

放射疗法可能增强转移性葡萄膜黑色素瘤患者对免疫疗法的反应。

Grynberg, Shirly; Stoff, Ronen; Asher, Nethanel; Shapira-Frommer, Ronnie; Schachter, Jacob; Haisraely, Ory; Lawrence, Yaacov; Ben-Betzalel, Guy

Oncologic patients' misconceptions may impede enrollment into clinical trials: a cross-sectional study

肿瘤患者的误解可能会阻碍他们参与临床试验:一项横断面研究

Asher, Nethanel; Raphael, Ari; Wolf, Ido; Pelles, Sharon; Geva, Ravit